Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,059 | -24,277 | -19,259 | -12,401 | -5,360 |
| Depreciation Amortization | 67 | 285 | 215 | 145 | 74 |
| Accounts receivable | N/A | 1,067 | N/A | 624 | 323 |
| Other Working Capital | 1,002 | 2,990 | 3,067 | 1,524 | 1,093 |
| Other Operating Activity | 4 | 615 | 1,305 | 286 | 182 |
| Operating Cash Flow | $-3,986 | $-19,320 | $-14,672 | $-9,822 | $-3,688 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,005 | 1,027 | -11 | -1 | -8 |
| PPE Investments | N/A | -29 | -29 | -28 | -9 |
| Investing Cash Flow | $2,005 | $998 | $-40 | $-29 | $-17 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,230 | 238 | N/A | N/A | N/A |
| Financing Cash Flow | $3,230 | $238 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 772 | 18,856 | 18,856 | 18,856 | 18,856 |
| End Cash Position | 2,021 | 772 | 4,144 | 9,005 | 15,151 |
| Net Cash Flow | $1,249 | $-18,084 | $-14,712 | $-9,851 | $-3,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,986 | -19,320 | -14,672 | -9,822 | -3,688 |
| Capital Expenditure | N/A | -29 | -29 | -28 | -9 |
| Free Cash Flow | -3,986 | -19,349 | -14,701 | -9,850 | -3,697 |